Intramuscular (IM) Injections Intramuscular injections involve delivering the B12 injection directly into the muscle tissue
Both endothelial cells and aortic sections were treated with 0.5% (v/v) Triton X-100 for 15 min, followed by three washes with PBS, each time for 5 min, and then blocked with 5% (v/v) bovine serum albumin (BSA, Sigma-Aldrich, B2064) at room temperature for 1 h
Mucosal Layer Optimization: Quantifying improvements in localized gastric mucous secretion thickness and cellular composition to isolate the triggers of wound healing in severe ulcer or colitis models
Avils-Gaxiola, S., Garca-Aguiar, I., Jimnez-Ortega, L
BPC-157 is not accurately described as a GLP-1, GIP, or glucagon receptor agonist
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al